ICVS Advanced Seminar “IPLEXMED: Driving the Next Generation of Diagnostics from Lab to Life”

October 2nd at 1 pm, don’t miss Bruno Almeida's "IPLEXMED: Driving the Next Generation of Diagnostics from Lab to Life" at the A0.03 auditorium in UMinho’s School of Medicine. IPLEXMED, a spin-off from the University of Minho and INL, is developing NEXAGUARD®—a portable, graphene-based diagnostic platform delivering lab-quality results in 20 minutes at the point of care or at home. Validated at TRL 6 with multiple patents filed, it targets bacterial respiratory infections and AMR, with plans to expand to STDs, sepsis, and hospital-acquired infections. Market launch is set for 2027 with a scalable “razor-and-blade” model, driving faster diagnostics, improved…

ICVS Advanced Seminar “Exploring the Microbiome in Colorectal Cancer: Implications for Prevention, Diagnosis, and Therapy Response”

October 9th at 1 pm, don’t miss Rui M. Reis's “Exploring the Microbiome in Colorectal Cancer: Implications for Prevention, Diagnosis, and Therapy Response” at the A0.01 auditorium in UMinho’s School of Medicine. Rui Manuel Reis, PhD, has dedicated nearly three decades to cancer research, primarily focusing on molecular pathology to discover and validate biomarkers. He is an Invited Associate Professor at the School of Medicine, University of Minho, Portugal, and serves as Scientific Director of the Barretos Cancer Hospital, Brazil. In this seminar, he will share his recent research on the interaction between the microbiome and colorectal cancer.

ICVS Student Seminar “Neuroprotective and pro-dopaminergic effects of the secretome from hypoxic and normoxic iMSCs cultured under dynamic conditions in Parkinson’s Disease in vitro models””

October 13th at 1 pm, don’t miss Alessander Leyendecker Junior's "Neuroprotective and pro-dopaminergic effects of the secretome from hypoxic and normoxic iMSCs cultured under dynamic conditions in Parkinson’s Disease in vitro models" at the A0.02 auditorium in UMinho’s School of Medicine.